These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19586787)

  • 1. AAV3-mediated transfer and expression of the pyruvate dehydrogenase E1 alpha subunit gene causes metabolic remodeling and apoptosis of human liver cancer cells.
    Glushakova LG; Lisankie MJ; Eruslanov EB; Ojano-Dirain C; Zolotukhin I; Liu C; Srivastava A; Stacpoole PW
    Mol Genet Metab; 2009 Nov; 98(3):289-99. PubMed ID: 19586787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A combined therapeutic approach for pyruvate dehydrogenase deficiency using self-complementary adeno-associated virus serotype-specific vectors and dichloroacetate.
    Han Z; Berendzen K; Zhong L; Surolia I; Chouthai N; Zhao W; Maina N; Srivastava A; Stacpoole PW
    Mol Genet Metab; 2008 Apr; 93(4):381-7. PubMed ID: 18206410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of Pyruvate Dehydrogenase E1α Subunit Inhibits Warburg Effect and Induces Cell Apoptosis Through Mitochondria-Mediated Pathway in Hepatocellular Carcinoma.
    Sun J; Li J; Guo Z; Sun L; Juan C; Zhou Y; Gu H; Yu Y; Hu Q; Kan Q; Yu Z
    Oncol Res; 2019 Mar; 27(4):407-414. PubMed ID: 29444744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of expression of rat pyruvate dehydrogenase E1alpha gene by self-complementary adeno-associated virus-mediated small interfering RNA delivery.
    Han Z; Gorbatyuk M; Thomas J; Lewin AS; Srivastava A; Stacpoole PW
    Mitochondrion; 2007 Jul; 7(4):253-9. PubMed ID: 17392036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy for pyruvate dehydrogenase E1alpha deficiency using recombinant adeno-associated virus 2 (rAAV2) vectors.
    Owen R; Mandel RJ; Ammini CV; Conlon TJ; Kerr DS; Stacpoole PW; Flotte TR
    Mol Ther; 2002 Sep; 6(3):394-9. PubMed ID: 12231176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An animal model of PDH deficiency using AAV8-siRNA vector-mediated knockdown of pyruvate dehydrogenase E1α.
    Ojano-Dirain C; Glushakova LG; Zhong L; Zolotukhin S; Muzyczka N; Srivastava A; Stacpoole PW
    Mol Genet Metab; 2010; 101(2-3):183-91. PubMed ID: 20685142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AAV3-miRNA vectors for growth suppression of human hepatocellular carcinoma cells in vitro and human liver tumors in a murine xenograft model in vivo.
    Yin L; Keeler GD; Zhang Y; Hoffman BE; Ling C; Qing K; Srivastava A
    Gene Ther; 2021 Aug; 28(7-8):422-434. PubMed ID: 32152434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pyruvate dehydrogenase complex as a target for gene therapy.
    Stacpoole PW; Owen R; Flotte TR
    Curr Gene Ther; 2003 Jun; 3(3):239-45. PubMed ID: 12762482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ilimaquinone Induces the Apoptotic Cell Death of Cancer Cells by Reducing Pyruvate Dehydrogenase Kinase 1 Activity.
    Kwak CH; Jin L; Han JH; Han CW; Kim E; Cho M; Chung TW; Bae SJ; Jang SB; Ha KT
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-efficiency transduction of liver cancer cells by recombinant adeno-associated virus serotype 3 vectors.
    Ling C; Lu Y; Cheng B; McGoogan KE; Gee SW; Ma W; Li B; Aslanidi GV; Srivastava A
    J Vis Exp; 2011 Mar; (49):. PubMed ID: 21445055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased superoxide accumulation in pyruvate dehydrogenase complex deficient fibroblasts.
    Glushakova LG; Judge S; Cruz A; Pourang D; Mathews CE; Stacpoole PW
    Mol Genet Metab; 2011 Nov; 104(3):255-60. PubMed ID: 21846590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Construction of a hepatoma-targeting vector of adeno-associated virus containing human alpha-fetoprotein promoter and wild p53 gene in gene therapy of liver cancer].
    Cheng J; Leng X; Peng J
    Zhonghua Yi Xue Za Zhi; 2000 Jun; 80(6):461-3. PubMed ID: 11798803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of optimized AAV3 serotype vectors: mechanism of high-efficiency transduction of human liver cancer cells.
    Cheng B; Ling C; Dai Y; Lu Y; Glushakova LG; Gee SW; McGoogan KE; Aslanidi GV; Park M; Stacpoole PW; Siemann D; Liu C; Srivastava A; Ling C
    Gene Ther; 2012 Apr; 19(4):375-84. PubMed ID: 21776025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of a targeting adenoviral vector carrying AFP promoter for expressing EGFP gene in AFP-producing hepatocarcinoma cell.
    Shi YJ; Gong JP; Liu CA; Li XH; Mei Y; Mi C; Huo YY
    World J Gastroenterol; 2004 Jan; 10(2):186-9. PubMed ID: 14716819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimized adeno-associated virus (AAV)-protein phosphatase-5 helper viruses for efficient liver transduction by single-stranded AAV vectors: therapeutic expression of factor IX at reduced vector doses.
    Jayandharan GR; Zhong L; Sack BK; Rivers AE; Li M; Li B; Herzog RW; Srivastava A
    Hum Gene Ther; 2010 Mar; 21(3):271-83. PubMed ID: 19788390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant adeno-associated virus vector-based gene transfer for defects in oxidative metabolism.
    Owen R IV; Lewin AP; Peel A; Wang J; Guy J; Hauswirth WW; Stacpoole PW; Flotte TR
    Hum Gene Ther; 2000 Oct; 11(15):2067-78. PubMed ID: 11044909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neglected foodborne mycotoxin Fusaric acid induces bioenergetic adaptations by switching energy metabolism from mitochondrial processes to glycolysis in a human liver (HepG2) cell line.
    Sheik Abdul N; Nagiah S; Chuturgoon AA
    Toxicol Lett; 2020 Jan; 318():74-85. PubMed ID: 31654802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and functional impact of clinically relevant E1α variants causing pyruvate dehydrogenase complex deficiency.
    Pavlu-Pereira H; Lousa D; Tomé CS; Florindo C; Silva MJ; de Almeida IT; Leandro P; Rivera I; Vicente JB
    Biochimie; 2021 Apr; 183():78-88. PubMed ID: 33588022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyr-301 phosphorylation inhibits pyruvate dehydrogenase by blocking substrate binding and promotes the Warburg effect.
    Fan J; Kang HB; Shan C; Elf S; Lin R; Xie J; Gu TL; Aguiar M; Lonning S; Chung TW; Arellano M; Khoury HJ; Shin DM; Khuri FR; Boggon TJ; Kang S; Chen J
    J Biol Chem; 2014 Sep; 289(38):26533-26541. PubMed ID: 25104357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lactic acidosis caused by repressed lactate dehydrogenase subunit B expression down-regulates mitochondrial oxidative phosphorylation via the pyruvate dehydrogenase (PDH)-PDH kinase axis.
    Hong SM; Lee YK; Park I; Kwon SM; Min S; Yoon G
    J Biol Chem; 2019 May; 294(19):7810-7820. PubMed ID: 30923124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.